Cash Flow Pharmarise Holdings Corp. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
May'26
May'25
May'24
May'23
May'22
May'21
No of Months
12
12
12
12
12
12
Profit Before Tax
698.00
8.00
143.00
1,049.00
1,322.00
1,202.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
1,304.00
39.00
1,785.00
595.00
-1,203.00
-77.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
3,278.00
1,311.00
2,714.00
2,520.00
713.00
1,945.00
Cash Flow from Investing Activities
-1,975.00
-4,462.00
-3,120.00
-703.00
-292.00
-1,076.00
Cash Flow from Financing Activities
-181.00
939.00
2,771.00
-1,072.00
-1,034.00
-728.00
Net Cash Inflow / Outflow
1,122.00
-2,212.00
2,365.00
745.00
-613.00
141.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Pharmarise Holdings Corp.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
698
-300.272
998.00
332.46%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
1304
44.576
1,260.00
2825.34%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
3278
-291.307
3,569.00
1225.27%
Cash Flow from Investing Activities
-1975
0
-1,975.00
0.00%
Cash Flow from Financing Activities
-181
1894.196
-2,075.00
-109.56%
Net Cash Inflow / Outflow
1122
1602.889
-480.00
-30.00%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - May'26
YoY Growth in year ended May 2026 is 150.04% vs -51.69% in May 2025
May'26
May'25
Change(%)
Cash Flow from Operating Activities
3,278.00
1,311.00
150.04%
Footer loading
